Genetic markers used for risk stratification in multiple myeloma.

Genetics Research International
Priscilla Segges, Esteban Braggio

Abstract

While no specific genetic markers are required in the diagnosis of multiple myeloma (MM), multiple genetic abnormalities and gene signatures are used in disease prognostication and risk stratification. This is particularly important for the adequate identification of the high-risk MM group, which does not benefit from any of the current therapies, and novel approaches need to be proposed. Fluorescence in situ hybridization (FISH) has been employed for establishing risk-based stratification and still remains the most used genetic technique in the clinical routine. The incorporation of gene expression profiling (GEP) in the study of MM has shown to be a very powerful test in the patient stratification, but its incorporation in clinical routine depends on some technical and logistic resolutions. Thus, FISH still remains the gold standard test for detecting genomic abnormalities and outcome discrimination in MM.

References

Jun 30, 2000·American Journal of Clinical Pathology·J D HoyerP J Kurtin
Mar 3, 2004·Cancer Research·Rafael FonsecaHerve Avet-Loiseau
Oct 29, 2004·The New England Journal of Medicine·Robert A Kyle, S Vincent Rajkumar
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P Leif Bergsagel, W Michael Kuehl
May 27, 2006·Blood·Fenghuang ZhanJohn D Shaughnessy
Nov 13, 2007·Hematology/oncology Clinics of North America·Rafael Fonseca, Jesus San Miguel
Dec 12, 2007·Best Practice & Research. Clinical Haematology·W J ChngW M Kuehl
Aug 30, 2008·The New England Journal of Medicine·Jesús F San MiguelUNKNOWN VISTA Trial Investigators
Oct 3, 2009·Leukemia·R FonsecaUNKNOWN International Myeloma Working Group
Dec 17, 2009·The Cancer Journal·Jesus San-MiguelNorma C Gutierrez
Apr 15, 2010·Blood·Margaret L MacMillanDaniel J Weisdorf
Oct 22, 2010·Blood·Moshe E GattDaniel R Carrasco
Oct 22, 2010·Blood·Hervé Avet-LoiseauUNKNOWN Intergroupe Francophone du Myélome

❮ Previous
Next ❯

Citations

Aug 3, 2017·Terapevticheskiĭ arkhiv·T V AbramovaV G Savchenko

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

GEP

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.